Vivtex

Vivtex originated from MIT, with a mission to enable the development of new oral drugs using sophisticated high throughput screening technologies, IP protected formulation libraries and molecular modeling/AI techniques. Vivtex has R&D collaborations with leading biotechnology and pharmaceutical companies with several oral peptide programs at the pre-clinical to clinical stage. Our vision is to empower patients with a choice of how to take their medicine.